September 5, 2024
(Reuters) – Explosive demand and high prices for Novo Nordisk and Eli Lilly’s weight loss and diabetes drugs have fueled a criminal effort to package autoinjector […]
September 5, 2024
TOPLINE: Older adults with acute uncomplicated appendicitis who were operated on within 1 day of admission were less likely to die in the hospital compared with […]
September 5, 2024
TOPLINE: A history of migraine is not associated with an elevated risk for Parkinson’s disease (PD) in women, regardless of headache frequency or migraine subtype, a […]
September 5, 2024
CARLSBAD, Calif. — The US Food and Drug Administration (FDA) approvals of tapinarof 1% cream and roflumilast 0.3% cream as treatment options for patients with plaque […]
September 5, 2024
TOPLINE: Women who received false-negative mammography results were less likely to return for future screenings. METHODOLOGY: Researchers analyzed more than three million screening mammograms from more […]
September 5, 2024
TOPLINE: In patients with prostate cancer, androgen receptor pathway inhibitors (ARPIs) extended the median time to no longer clinically benefitting (NLCB) to 11.1 months vs the […]
September 5, 2024
TOPLINE: Childhood obesity is linked to a higher risk for pediatric skin diseases linked to immunity, including alopecia areata, atopic dermatitis, and psoriasis. Transitioning from normal […]
September 4, 2024
TOPLINE: Teclistamab, a T-cell engager that targets B-cell maturation antigen (BCMA), improved disease activity in four patients with refractory autoimmune conditions. In a separately published case […]
September 4, 2024
The Medicines and Healthcare Products Regulatory Agency (MHRA) has granted a licence for relugolix combination therapy (Ryeqo, Gedeon Richter) for the symptomatic treatment of endometriosis in […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482
Next page